contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


aqua-bio-technology-asa-share-capital-increase-registered-12

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Aqua Bio Technology is a Norwegian company operating in the cosmetics industry. The company develops, manufactures and commercializes ingredients that are used in various cosmetic products worldwide. The largest business is in solutions for skin care products. Most of the company's products are sold on a global market through various distributors. The company was founded in 2004 and has its headquarters in Lysaker.

Aqua Bio Technology

Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the agreement with the sellers of Jetcarrier AS to convert...

<div class="mfn-body"><p>Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the agreement with the sellers of Jetcarrier AS to convert NOK 50,000,000 of the currently outstanding seller credit into new shares in the Company at the same subscription price as in the private placement that was carried out by the Company 12 February 2026 (the "Conversion"). Reference is further made to the stock exchange announcement by the Company on 13 March 2026 regarding the completion of the extraordinary general meeting in the Company. The general meeting inter alia resolved to increase the Company's share capital by NOK 50,000,000 through the issuance of 10,000,000 new shares in connection with the Conversion, each with a par value of NOK 5.00.</p><p>&nbsp;</p><p>The share capital increase pertaining to the Conversion has now been registered with the Norwegian Register of Business Enterprises. The new share capital of ABTEC is NOK 76,139,675 divided by 15,227,935 shares, each with a par value of NOK 5.00.</p></div><div class="mfn-footer mfn-contacts mfn-76be5d61d270"><p><strong class="mfn-heading-1">Contacts</strong><br><strong>Kristian Flaten</strong><br><strong>CEO &amp; CFO</strong><br><strong>Aqua Bio Technology ASA</strong></p><p>Phone: +47 9509 2322<br>Email: <a href="mailto:kf@aquabiotech.no" rel="noopener">kf@aquabiotech.no</a></p></div><div class="mfn-footer mfn-about mfn-4705b2e2e705"><p><strong class="mfn-heading-1">About Us</strong><br>Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.</p><p>This notice is published by Kristian Flaten on the listed date and time. </p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar-nsta"><p><em>This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-23 12:02 CET.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a class="mfn-generated mfn-primary" href="https://storage.mfn.se/d7ae77e9-18e8-48c7-805e-83d230cdad5a/aqua-bio-technology-asa-share-capital-increase-registered.pdf" rel="noopener">Aqua Bio Technology ASA: Share capital increase registered</a></p></div>

Aqua Bio Technology ASA: Share capital increase registered

Intervjuer i samband med Stockholm Corporate Finance 17:e Kapitalmarknadsdagar Life Science 2026

Return on capital (ROE, ROI, ROIC, RONIC)

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Finanslingo enkelt förklarat: EBIT, EBITA och EBITDA 

Stora företag är dyrare, men finns det värde i små företag?